Showing results (211-220 of 289) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombusZhao-Chong Zeng, Jia Fan, Zhao-You Tang, et al.
BMC Complementary and Alternative Medicine|April 30, 2013
Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cellsQing-An Jia, Zhi-Ming Wang, Zheng-Gang Ren, et al.
Cancer Letters|October 14, 2009
Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cellsTi Zhang, Hui-Chuan Sun, Hong-Yuan Zhou, et al.
Cancer|October 13, 2011
HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resectionYi-Ming Zhao, Jia-Min Zhou, Long-Rong Wang, et al.
International Journal of Biological Sciences|December 7, 2017
Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expressionYulin Sun, Fubo Ji, Mia R Kumar, et al.
BMC Cancer|May 22, 2010
Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou YinWei Xiong, Zheng-Gang Ren, Shuang-Jian Qiu, et al.
International Journal of Nanomedicine|August 14, 2012
The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)Haitham Amal, Lu Ding, Bin-bin Liu, et al.
Hepatology (Baltimore, Md.)|January 8, 2008
Identification of metastasis-related microRNAs in hepatocellular carcinomaAnuradha Budhu, Hu-Liang Jia, Marshonna Forgues, et al.
Cell Death & Disease|May 1, 2018
The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis targetCheng-Dong Qin, De-Ning Ma, Shi-Zhe Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinomaJin-Zhong Pang, Lun-Xiu Qin, Ning Ren, et al.
Pageof 29